|
CCNB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.478600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.165800E-01 |
| Normal-vs-Stage2 |
4.143800E-01 |
| Normal-vs-Stage3 |
7.814200E-01 |
| Normal-vs-Stage4 |
7.203200E-01 |
| Stage1-vs-Stage2 |
3.436000E-02 |
| Stage1-vs-Stage3 |
6.624000E-01 |
| Stage1-vs-Stage4 |
5.396200E-01 |
| Stage2-vs-Stage3 |
4.341900E-02 |
| Stage2-vs-Stage4 |
3.304300E-02 |
| Stage3-vs-Stage4 |
8.774400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.577000E-01 |
| Normal-vs-AfricanAmerican |
7.908000E-01 |
| Normal-vs-Asian |
9.270600E-01 |
| Caucasian-vs-AfricanAmerican |
4.003600E-01 |
| Caucasian-vs-Asian |
6.227400E-01 |
| AfricanAmerican-vs-Asian |
5.469200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.504800E-01 |
| Normal-vs-Female |
9.866600E-01 |
| Male-vs-Female |
6.352800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.509000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.002600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.861800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.251700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.230210E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.669600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.009400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.552600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.463150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.643780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.891400E-01 |
| Classical-VS-Follicular |
3.92040000000149E-05 |
| Classical-VS-Other |
5.366300E-02 |
| Classical-VS-Normal |
7.036600E-01 |
| Tall-VS-Follicular |
1.819070E-03 |
| Tall-VS-Other |
1.281410E-01 |
| Tall-VS-Normal |
5.150600E-01 |
| Follicular-VS-Other |
7.867600E-01 |
| Follicular-VS-Normal |
3.022200E-01 |
| Other-VS-Normal |
4.732200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.252200E-01 |
| Normal-vs-N1 |
8.914400E-01 |
| N0-vs-N1 |
8.284200E-01 |
|
|
